481 related articles for article (PubMed ID: 1384948)
41. Prognostic importance of flow cytometric immunophenotyping of 540 consecutive patients with B-cell chronic lymphocytic leukemia.
Geisler CH; Larsen JK; Hansen NE; Hansen MM; Christensen BE; Lund B; Nielsen H; Plesner T; Thorling K; Andersen E
Blood; 1991 Oct; 78(7):1795-802. PubMed ID: 1717071
[TBL] [Abstract][Full Text] [Related]
42. Interleukin 1 (IL-1 alpha and IL-1 beta) induces differentiation/activation of B cell chronic lymphoid leukemia cells.
Takeuchi H; Katayama I
Cytokine; 1994 May; 6(3):243-6. PubMed ID: 8054479
[TBL] [Abstract][Full Text] [Related]
43. Bryostatin 1-induced hairy cell features on chronic lymphocytic leukemia cells in vitro.
al-Katib A; Mohammad RM; Dan M; Hussein ME; Akhtar A; Pettit GR; Sensenbrenner LL
Exp Hematol; 1993 Jan; 21(1):61-5. PubMed ID: 8093352
[TBL] [Abstract][Full Text] [Related]
44. The complementary roles of surface-immunoglobulin clonality and fluorescence intensity, mouse rosettes, and cd5 in the diagnosis of B-chronic lymphocytic-leukemia.
Batata A; Shen B; Yanes B; Nicholson G; Hines D; Chang J; Gross H; Llenadolee M; Merle S
Int J Oncol; 1993 Mar; 2(3):425-30. PubMed ID: 21573572
[TBL] [Abstract][Full Text] [Related]
45. Mouse erythrocyte rosette formation with malignant human B-lymphocytes re-evaluated: still a useful marker for differentiating mature B-cell malignancies.
Hokland P; Geisler CH; Andersen E; Drivsholm A; Hansen MM; Meyer K
Br J Haematol; 1992 Nov; 82(3):560-4. PubMed ID: 1283079
[TBL] [Abstract][Full Text] [Related]
46. Flow cytometry of peripheral blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells, lymphocyte subsets and detection of minimal residual disease after treatment.
Babuŝíková O; Tomová A; Kusenda J; Gyárfás J
Neoplasma; 2001; 48(5):350-7. PubMed ID: 11845978
[TBL] [Abstract][Full Text] [Related]
47. Atypical chronic lymphocytic leukaemia with t(11;14)(q13;q32): karyotype evolution and prolymphocytic transformation.
Cuneo A; Balboni M; Piva N; Rigolin GM; Roberti MG; Mejak C; Moretti S; Bigoni R; Balsamo R; Cavazzini P
Br J Haematol; 1995 Jun; 90(2):409-16. PubMed ID: 7794764
[TBL] [Abstract][Full Text] [Related]
48. Reduced expression of CD20 antigen as a characteristic marker for chronic lymphocytic leukemia.
Almasri NM; Duque RE; Iturraspe J; Everett E; Braylan RC
Am J Hematol; 1992 Aug; 40(4):259-63. PubMed ID: 1380203
[TBL] [Abstract][Full Text] [Related]
49. [Expression of proliferation marker Ki 67 in chronic lymphocytic leukemia].
Diop S; Letestu R; Orsolani D; Leboeuf Y; Le Tutour P; Thiam D; Diakhate L; Valensi F
Dakar Med; 2005; 50(2):65-8. PubMed ID: 16295759
[TBL] [Abstract][Full Text] [Related]
50. Clinico-prognostic relevance of quantitative immunophenotyping in B-cell chronic lymphocytic leukemia with emphasis on the expression of CD20 antigen and surface immunoglobulins.
Molica S; Levato D; Dattilo A; Mannella A
Eur J Haematol; 1998 Jan; 60(1):47-52. PubMed ID: 9451427
[TBL] [Abstract][Full Text] [Related]
51. Simultaneous manifestation of chronic lymphocytic leukemia (CLL) and hairy cell leukemia (HCL).
Sokol L; Agosti SJ
Am J Hematol; 2004 Feb; 75(2):107-9. PubMed ID: 14755378
[TBL] [Abstract][Full Text] [Related]
52. Immunophenotype does not correlate with lymph node histology in chronic lymphocytic leukemia/small lymphocytic lymphoma.
Asplund SL; McKenna RW; Howard MS; Kroft SH
Am J Surg Pathol; 2002 May; 26(5):624-9. PubMed ID: 11979092
[TBL] [Abstract][Full Text] [Related]
53. Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment.
Kusenda J; Babusíková O
Neoplasma; 2004; 51(2):97-102. PubMed ID: 15190418
[TBL] [Abstract][Full Text] [Related]
54. [Relevance of cytological and immunophenotypical analysis for the diagnosis of B-cell chronic lymphocytic leukaemia].
Guillaume N; Alimardani G; Capiod JC; Claisse JF
Ann Biol Clin (Paris); 2002; 60(6):673-81. PubMed ID: 12446231
[TBL] [Abstract][Full Text] [Related]
55. Pan B-cell markers are not redundant in analysis of chronic lymphocytic leukemia (CLL).
Monaghan SA; Peterson LC; James C; Marszalek L; Khoong A; Bachta DJ; Karpus WJ; Goolsby CL
Cytometry B Clin Cytom; 2003 Nov; 56(1):30-42. PubMed ID: 14582135
[TBL] [Abstract][Full Text] [Related]
56. Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group.
Bennett JM; Catovsky D; Daniel MT; Flandrin G; Galton DA; Gralnick HR; Sultan C
J Clin Pathol; 1989 Jun; 42(6):567-84. PubMed ID: 2738163
[TBL] [Abstract][Full Text] [Related]
57. Morphological and immunophenotypic features of chronic lymphocytic leukemia.
Matutes E; Polliack A
Rev Clin Exp Hematol; 2000 Mar; 4(1):22-47. PubMed ID: 11486329
[TBL] [Abstract][Full Text] [Related]
58. B-zone small lymphocytic lymphoma: a morphologic, immunophenotypic, and clinical study with comparison to "well-differentiated" lymphocytic disorders.
Carbone A; Pinto A; Gloghini A; Volpe R; Zagonel V
Hum Pathol; 1992 Apr; 23(4):438-48. PubMed ID: 1563746
[TBL] [Abstract][Full Text] [Related]
59. Surface antigen expression in chronic lymphocytic leukemia: clustering analysis, interrelationships and effects of chromosomal abnormalities.
Hulkkonen J; Vilpo L; Hurme M; Vilpo J
Leukemia; 2002 Feb; 16(2):178-85. PubMed ID: 11840283
[TBL] [Abstract][Full Text] [Related]
60. Immune phenotype and some enzyme patterns in phorbol ester-induced chronic lymphocytic leukemia cells.
Babusíková O; Mesárosová A; Kusenda J; Koníková E; Klobusická M; Hrivnáková A
Neoplasma; 1995; 42(5):221-6. PubMed ID: 8552199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
